Identifying Ways to Reduce Readmissions Among Minority-Serving U.S. Hospitals
确定减少为少数族裔服务的美国医院再入院率的方法
基本信息
- 批准号:8644879
- 负责人:
- 金额:$ 39.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-04-01 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Acute myocardial infarction (AMI), congestive heart failure (CHF), and pneumonia are three of the most common reasons for hospitalization in the Medicare program, and each is associated with high 30-day readmission rates. Although readmissions are common across all patient groups, black patients are more likely than white patients to be readmitted for reasons that are not well understood. The site of care likely plays an important role: care for minorities is concentrated among a small number of minority-serving hospitals (MSHs), which provide a lower quality of care and have worse outcomes, including higher readmission rates. However, even among MSHs, there are large variations: in preliminary analyses, we found three-fold variations in readmission rates (e.g. for AMI, 12.2% in the best versus 35.7% in the worst quartile) with some MSHs achieving results comparable to the best hospitals nationally. The Affordable Care Act (ACA) has made reducing readmissions a priority by requiring that Medicare lower payments to hospitals with high readmission rates and in preliminary analyses for this proposal, we found that MSHs have nearly three times greater odds of being in the worst quartile of performance nationally. If these hospitals fail to improve, the new policy is likely to worsen existing disparities in care. However, we know little about why some MSHs have low readmission rates while others lag behind. Helping MSHs reduce readmissions is critically important, but we lack the empirical data to make evidence-based recommendations. We propose to examine key patient-, hospital-, and market-level factors that explain the large variations in readmission among MSHs, and determine if the presence of these factors explains gaps in performance between MSHs and non-MSHs. We will use case studies to characterize readmission prevention practices at MSHs with the highest and lowest risk-adjusted readmission rates. We will then use a national survey of hospital Chief Medical Officers to create the first national picture of current knowledge, priorities, and programs around
readmissions. Finally, we will use administrative databases to examine the degree to which these factors explain variations in readmissions among MSHs, whether the important factors we identify also explain variation at non-MSHs, and whether they explain disparities between non-MSHs and MSHs. Understanding the substantial variations in readmission rates among MSHs will allow us to identify key factors that are actionable and relevant to MSHs. These data will help policymakers craft effective and novel interventions help MSHs improve care for all their patients, thus reducing disparities in readmissions.
描述(由申请人提供):急性心肌梗塞(AMI),充血性心力衰竭(CHF)和肺炎是Medicare计划中住院治疗的三个最常见原因,并且每种原因都与30天的高30天有关。尽管在所有患者群体中的再入院都是常见的,但由于不太了解的原因,黑人患者比白人患者更有可能被重新入院。护理现场可能起着重要作用:对少数族裔的护理集中在少数少数族裔医院(MSHS)中,这些医院提供了较低的护理质量,并且结果较差,包括更高的再入院率。但是,即使在MSH中,也有很大的变化:在初步分析中,我们发现再入院率的三倍变化(例如,对于AMI,最佳四分位数中最佳的35.7%,而在最差的四分位数中为35.7%),一些MSHS可与最佳医院相提并论。 《平价医疗法案》(ACA)通过要求医疗保险向具有高入院率的医院付款,并在对该提案的初步分析中,将减少再选项减少了,我们发现MSH在全国绩效最差的Quartile中的几乎三倍。如果这些医院无法改善,新政策可能会加剧现有的护理差异。但是,我们对为什么有些MSH的再入院率较低,而另一些人则落后,我们一无所知。帮助MSH减少再入院至关重要,但我们缺乏经验数据来提出基于证据的建议。我们建议检查关键的患者,医院和市场水平的因素,这些因素可以解释MSH之间的重大差异,并确定这些因素的存在是否解释了MSH和非MSH之间的性能差距。我们将使用案例研究来表征最高和最低风险调整后再入院率的MSH的再入院惯例。然后,我们将使用全国医院首席医疗官调查,以创建有关当前知识,优先事项和计划的首个国家图片
再入院。最后,我们将使用管理数据库来检查这些因素解释MSH的再入院式变化的程度,我们确定的重要因素是否也解释了非MSH的变化,以及它们是否解释了非MSH和MSH之间的差异。了解MSH的再入院率的实质性变化将使我们能够确定与MSH相关的关键因素。这些数据将有助于决策者制定有效和新颖的干预措施,有助于MSH改善对所有患者的护理,从而减少再入院率的差异。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Opinions on the Hospital Readmission Reduction Program: results of a national survey of hospital leaders.
- DOI:
- 发表时间:2016-08
- 期刊:
- 影响因子:0
- 作者:Karen E. Joynt;José Figueroa;John Oray;A. Jha
- 通讯作者:Karen E. Joynt;José Figueroa;John Oray;A. Jha
共 1 条
- 1
ASHISH K JHA的其他基金
Trends in Racial Disparities in Surgical Readmissions and Strategies to Narrow the Gap
再入院手术的种族差异趋势和缩小差距的策略
- 批准号:95729599572959
- 财政年份:2017
- 资助金额:$ 39.49万$ 39.49万
- 项目类别:
Understanding Disparities in Patient-Centered Hospital Care
了解以患者为中心的医院护理中的差异
- 批准号:86006318600631
- 财政年份:2012
- 资助金额:$ 39.49万$ 39.49万
- 项目类别:
Identifying Ways to Reduce Readmissions Among Minority-Serving U.S. Hospitals
确定减少为少数族裔服务的美国医院再入院率的方法
- 批准号:84518958451895
- 财政年份:2012
- 资助金额:$ 39.49万$ 39.49万
- 项目类别:
Identifying Ways to Reduce Readmissions Among Minority-Serving U.S. Hospitals
确定减少为少数族裔服务的美国医院再入院率的方法
- 批准号:82752908275290
- 财政年份:2012
- 资助金额:$ 39.49万$ 39.49万
- 项目类别:
Understanding Disparities in Patient-Centered Hospital Care
了解以患者为中心的医院护理中的差异
- 批准号:84495908449590
- 财政年份:2012
- 资助金额:$ 39.49万$ 39.49万
- 项目类别:
Understanding Disparities in Patient-Centered Hospital Care
了解以患者为中心的医院护理中的差异
- 批准号:82819278281927
- 财政年份:2012
- 资助金额:$ 39.49万$ 39.49万
- 项目类别:
相似国自然基金
指向提议者的共情关怀对第三方惩罚行为的影响:心理、脑与计算机制
- 批准号:32371102
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
关怀效应与守门效应:员工-AI算法协作、任务情境与算法透明度对用户反应的影响
- 批准号:72372071
- 批准年份:2023
- 资助金额:42 万元
- 项目类别:面上项目
生命权视角下癌症晚期患者临终意愿依从性指标评估体系及管理模型构建
- 批准号:71904056
- 批准年份:2019
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
癌症患儿的康复景观与健康关怀实践:中美比较视角
- 批准号:41861029
- 批准年份:2018
- 资助金额:38.0 万元
- 项目类别:地区科学基金项目
晚期肿瘤患者“预立医疗照护计划”干预模式的构建及其实证研究
- 批准号:71663064
- 批准年份:2016
- 资助金额:30.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Oral Antivirals against COVID-19 and Clinical Outcomes in High Risk Populations
针对 COVID-19 的口服抗病毒药物和高危人群的临床结果
- 批准号:1057480610574806
- 财政年份:2023
- 资助金额:$ 39.49万$ 39.49万
- 项目类别:
The Impacts of Racial Discrimination and Disrespectful Maternity Care on Severe Maternal Morbidity Among Black Birthing People in The United States
种族歧视和不尊重的产妇护理对美国黑人新生儿严重孕产妇发病率的影响
- 批准号:1053637610536376
- 财政年份:2022
- 资助金额:$ 39.49万$ 39.49万
- 项目类别:
The Impacts of Racial Discrimination and Disrespectful Maternity Care on Severe Maternal Morbidity Among Black Birthing People in The United States
种族歧视和不尊重的产妇护理对美国黑人新生儿严重孕产妇发病率的影响
- 批准号:1068906910689069
- 财政年份:2022
- 资助金额:$ 39.49万$ 39.49万
- 项目类别:
Disruptions in ST-Elevation Myocardial Infarction Transfer Networks and Cardiovascular Health of Rural Americans
ST 段抬高心肌梗死转移网络和美国农村心血管健康的中断
- 批准号:1040095610400956
- 财政年份:2021
- 资助金额:$ 39.49万$ 39.49万
- 项目类别:
Disruptions in ST-Elevation Myocardial Infarction Transfer Networks and Cardiovascular Health of Rural Americans
ST 段抬高心肌梗死转移网络和美国农村心血管健康的中断
- 批准号:1021082010210820
- 财政年份:2021
- 资助金额:$ 39.49万$ 39.49万
- 项目类别: